Page last updated: 2024-08-24

trofosfamide and Carcinoma, Anaplastic

trofosfamide has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Batran, SE; Atmaca, A; Bert, F; Frisch, C; Jäger, D; Jäger, E; Knuth, A; Neumann, A; Orth, J	1

Trials

1 trial(s) available for trofosfamide and Carcinoma, Anaplastic

Article	Year
Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer. Onkologie, 2004, Volume: 27, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Risk Assessment; Risk Factors	2004

Article

Year

Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.

Onkologie, 2004, Volume: 27, Issue:6

Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Risk Assessment; Risk Factors

2004